← Open Payments lookup

LEONARD MARCUS: Open Payments

NPI 1730165119 · RANDOLPH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$376 in 20 payments from 10 companies in 2025. Trend: 2023 $178 · 2024 $251 · 2025 $376

Food & beverage: $376
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$82
Alkermes, Inc.3$61
ABBVIE INC.3$45
Neurocrine BioSciences, Inc.2$42
Teva Pharmaceuticals USA, Inc.2$41
Lundbeck LLC2$33
Janssen Pharmaceuticals, Inc1$21
Otsuka America Pharmaceutical, Inc.1$19
E.R. Squibb & Sons, L.L.C.1$17
Vanda Pharmaceuticals Inc.1$16

Products named: CAPLYTA, ARISTADA, REXULTI, VRAYLAR, INGREZZA, UZEDY, INVEGA SUSTENNA, COBENFY.

Industry payments across MA — which companies pay providers there.